The Global Biosensor Market is segmented on the basis of product type, application and end user. The report provides data for 2015 to 2024, 2016 being the current year while 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Access Full Report: https://www.databridgemarketresearch.com/reports/global-biosensors-market The global biosensor market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The Abbott is going to dominate the global biosensor market followed by Johnsons & Johnson Services, Inc., Medtronic and other players operating in this market are include DuPont, Bio-Rad Laboratories, Inc., Universal Biosensors Inc., Sysmex Corporation, Pharmaco-Kinesis, Nova Biomedical, ACON Laboratories, Inc., General Electric, DANAHER (Molecular devices, LLC), Drägerwerk AG & Co. KGaA, Ercon Inc., HMicro Inc. and Xsensio among others. Abbott: Abbott was incorporated in 1900 and headquartered in Illinois, U.S. It is a globally diversified healthcare company focused in discovery, development, manufacture, and marketing of broad line of health care products. It operates its business through four segments, established pharmaceutical products, diagnostic products, nutritional products, and vascular products. Abbott operates in more than 150 countries across United States, Europe, Western Hemisphere, Africa, and Asia-Pacific. For instance, Abbott Administration Inc. (Delaware), Abbott Home Infusion Services, Inc. (New york), Abbott Laboratories International Co. (Illinois), Abbott Australasia Pty Ltd.(Australia), Murex Diagnostics International, Inc. (Barbados), Abbott S.A. (Belgium). Johnson & Johnson Services, Inc.: Johnson & Johnson Services, Inc. founded in 1886 and headquartered at New Jersey, U.S. The company operates through three business segments, namely, Consumer, Pharmaceutical, and Medical Devices. The pharmaceutical segment offers a wide range of products for five major therapeutic applications—immunology, infectious diseases, neuroscience, oncology, and cardiovascular & metabolic diseases. The consumer segment of the company offers various products pertaining to baby care, oral care, skin care, women’s health, and wound care. The medical devices segment of the company offers various devices to be used in therapeutic areas such as orthopedic, surgical care, specialty surgery, cardiovascular care, diagnostics, diabetes care, and vision care. Ethicon US, LLC., subsidiary of Johnson & Johnson Services, Inc. is engaged in the development and marketing of healthcare products. Johnson & Johnson has more than 265 operating companies across the United States, Europe, Western Hemisphere, Africa, and Asia-Pacific. Some of its subsidiaries include Janssen Pharmaceuticals (Belgium), Ethicon Inc. (U.S.), DePuy (U.S.), Neutrogena (U.S.), Synthes (Switzerland), Cordis Corporation (U.S.), LifeScan, Inc. (U.S.), Janssen-Cilag (U.S.), McNeil Consumer Healthcare (U.S.), Janssen Biotech, Inc. (U.S.), Ortho Clinical Diagnostics (U.S.), and Mentor Worldwide LLC (U.S.). Medtronic: Medtronic was founded in 1949 and headquartered in Minneapolis, U.S. It is a global healthcare solutions company and it is the world’s largest standalone medical technology development company. The company operates in cardiac and vascular group, minimally invasive therapies group, restorative therapies group, and diabetes group. It offers absorbable and non-absorbable sutures through its subsidiaries brand name Covidien products. The company operates in more than 155 countries worldwide with more than 260 locations in research and development, manufacturing and distribution, and education centers. The company’s regional locations are Asia-Pacific, Eastern Europe, Latin America, Middle East and Africa, Central Asia, South Asia, North America, and Western Europe.
